SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-Q’ for 3/31/13 – ‘EX-101.CAL’

On:  Friday, 5/10/13, at 4:58pm ET   ·   For:  3/31/13   ·   Accession #:  1193125-13-214464   ·   File #:  0-19627

Previous ‘10-Q’:  ‘10-Q’ on 11/9/12 for 9/30/12   ·   Next:  ‘10-Q’ on 8/9/13 for 6/30/13   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/10/13  Biolase, Inc                      10-Q        3/31/13   61:3.9M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    313K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
40: R1          Document and Entity Information                     HTML     40K 
30: R2          Consolidated Balance Sheets                         HTML    135K 
38: R3          Consolidated Balance Sheets (Parenthetical)         HTML     47K 
42: R4          Consolidated Statements Of Operations And           HTML    102K 
                Comprehensive Loss                                               
55: R5          Consolidated Statements Of Cash Flows               HTML    128K 
32: R6          Basis of Presentation                               HTML     35K 
37: R7          Recent Accounting Pronouncements                    HTML     27K 
27: R8          Stock-Based Awards and Per Share Information        HTML     60K 
19: R9          Inventory                                           HTML     26K 
57: R10         Property, Plant, and Equipment                      HTML     32K 
44: R11         Intangible Assets and Goodwill                      HTML     46K 
43: R12         Accrued Liabilities and Deferred Revenue            HTML     43K 
48: R13         Lines Of Credit and Other Borrowings                HTML     27K 
49: R14         Commitments and Contingencies                       HTML     30K 
47: R15         Segment Information                                 HTML     32K 
50: R16         Concentrations                                      HTML     21K 
39: R17         Income Taxes                                        HTML     30K 
41: R18         Subsequent Events                                   HTML     24K 
46: R19         Accounting Policies (Policies)                      HTML     89K 
61: R20         Stock-Based Awards and Per Share Information        HTML     59K 
                (Tables)                                                         
52: R21         Inventory (Tables)                                  HTML     24K 
34: R22         Property, Plant, and Equipment (Tables)             HTML     30K 
45: R23         Intangible Assets and Goodwill (Tables)             HTML     40K 
36: R24         Accrued Liabilities and Deferred Revenue (Tables)   HTML     48K 
15: R25         Segment Information (Tables)                        HTML     25K 
53: R26         Basis of Presentation - Additional Information      HTML     44K 
                (Detail)                                                         
58: R27         Stock Based Awards and Per Share Information -      HTML     74K 
                Additional Information (Detail)                                  
23: R28         Classification of Compensation Expense Associated   HTML     27K 
                with Share-Based Payments (Detail)                               
22: R29         Assumptions Used in Estimating Fair Value of Stock  HTML     30K 
                Options Granted (Detail)                                         
25: R30         Summary of Option Activity (Detail)                 HTML     71K 
26: R31         Cash Proceeds Along with Fair Value Disclosures     HTML     37K 
                Related to grants Exercises and Vesting Options                  
                (Detail)                                                         
28: R32         Components of Inventory (Detail)                    HTML     31K 
14: R33         Inventory - Additional Information (Detail)         HTML     24K 
51: R34         Summary of Property, Plant, and Equipment (Detail)  HTML     36K 
33: R35         Property, Plant, and Equipment - Additional         HTML     21K 
                Information (Detail)                                             
35: R36         Intangible Assets and Goodwill - Additional         HTML     22K 
                Information (Detail)                                             
17: R37         Intangible Assets Related to Accumulated            HTML     51K 
                Amortization and Goodwill (Detail)                               
60: R38         Components of Accrued Liabilities (Detail)          HTML     43K 
12: R39         Changes In Initial Product Warranty Accrual and     HTML     37K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
29: R40         Summary of Deferred Revenue (Detail)                HTML     37K 
54: R41         Lines of Credit and Other Borrowings - Additional   HTML     66K 
                Information (Detail)                                             
16: R42         Commitments and Contingencies - Additional          HTML     37K 
                Information (Detail)                                             
21: R43         Segment Information - Additional Information        HTML     29K 
                (Detail)                                                         
24: R44         Summary of Net Revenue by Geographic Location       HTML     23K 
                (Detail)                                                         
31: R45         Concentrations - Additional Information (Detail)    HTML     29K 
13: R46         Income Taxes - Additional Information (Detail)      HTML     55K 
18: R47         Subsequent Events - Additional Information          HTML     54K 
                (Detail)                                                         
59: XML         IDEA XML File -- Filing Summary                      XML     90K 
20: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    425K 
 6: EX-101.INS  XBRL Instance -- biol-20130331                       XML    711K 
 8: EX-101.CAL  XBRL Calculations -- biol-20130331_cal               XML    159K 
 9: EX-101.DEF  XBRL Definitions -- biol-20130331_def                XML    678K 
10: EX-101.LAB  XBRL Labels -- biol-20130331_lab                     XML    991K 
11: EX-101.PRE  XBRL Presentations -- biol-20130331_pre              XML    767K 
 7: EX-101.SCH  XBRL Schema -- biol-20130331                         XSD    144K 
56: ZIP         XBRL Zipped Folder -- 0001193125-13-214464-xbrl      Zip    114K 


‘EX-101.CAL’   —   XBRL Calculations — biol-20130331_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- RR Donnelley Xcelerate Taxonomy Calculation Linkbase, based on XBRL 2.1 http://www.edgar-online.com/ -->
<!-- Version: 6.20.1 -->
<!-- Round: e0340d5a-ab4a-49d8-9dd9-69bd166a02b9 -->
<!-- Creation date: 2013-05-10T06:09:51Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DocumentDocumentandEntityInformation" roleURI="http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_StatementOfIncome" roleURI="http://www.biolase.com/taxonomy/role/StatementOfIncome"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureBasisOfPresentationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureStockBasedAwardsAndPerShareInformationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments" roleURI="http://www.biolase.com/taxonomy/role/DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureSummaryOfOptionActivity" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfOptionActivity"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions" roleURI="http://www.biolase.com/taxonomy/role/DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureComponentsOfInventory" roleURI="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfInventory"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureInventoryAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureInventoryAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureSummaryOfPropertyPlantAndEquipment" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipment"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosurePropertyPlantAndEquipmentAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureIntangibleAssetsAndGoodwillAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureComponentsOfAccruedLiabilities" roleURI="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccruedLiabilities"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties" roleURI="http://www.biolase.com/taxonomy/role/DisclosureChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureSummaryOfDeferredRevenue" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfDeferredRevenue"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureSegmentInformationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureSummaryOfNetRevenueByGeographicLocation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetRevenueByGeographicLocation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureConcentrationsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureIncomeTaxesAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#DisclosureSubsequentEventsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsAccountingChangesAndErrorCorrectionsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccountingChangesAndErrorCorrectionsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsConcentrationsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20130331.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="us-gaap_CustomerDepositsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_StockholdersEquityExcludingTreasuryStock" xlink:label="biol_StockholdersEquityExcludingTreasuryStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredTaxAssetsNetNoncurrent" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.1800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1.2700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LinesOfCreditCurrent" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_CustomerDepositsCurrent" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="1.1500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="biol_StockholdersEquityExcludingTreasuryStock" order="1.2500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_TreasuryStockValue" order="1.2600" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_PreferredStockValue" order="1.2000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_CommonStockValue" order="1.2100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.2200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.2300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.2400" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfIncome">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_ExciseTax" xlink:label="biol_ExciseTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_LicenseFeesAndRoyaltyRevenue" xlink:label="biol_LicenseFeesAndRoyaltyRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_ProductsAndServicesRevenue" xlink:label="biol_ProductsAndServicesRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_SalesRevenueNet" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfGoodsSold" order="1.0400" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1.1500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1600" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="biol_ExciseTax" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1.1000" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_ProductsAndServicesRevenue" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_LicenseFeesAndRoyaltyRevenue" order="1.0200" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect">
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_AmortizationOfDiscountsOnLinesOfCredit" xlink:label="biol_AmortizationOfDiscountsOnLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerDeposits"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_OtherEquityInstrumentsCompensation" xlink:label="biol_OtherEquityInstrumentsCompensation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="1.2300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="1.2400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1.2000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="1.2100" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1.2200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.1700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.1800" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="biol_AmortizationOfDiscountsOnLinesOfCredit" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="biol_OtherEquityInstrumentsCompensation" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="1.0800" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="1.1000" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.1100" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.1200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInCustomerDeposits" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="1.1500" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfOptionActivity"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfInventory">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureInventoryAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipment">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0200" weight="-1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_FiniteLivedIntangibleAssetsImpairment" xlink:label="biol_FiniteLivedIntangibleAssetsImpairment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GoodwillGross" xlink:label="us-gaap_GoodwillGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="biol_FiniteLivedIntangibleAssetsImpairment" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_GoodwillGross" order="1.0400" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccruedLiabilities">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="us-gaap_AccruedInsuranceCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_SalesTaxPayableCurrent" xlink:label="biol_SalesTaxPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="biol_SalesTaxPayableCurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0600" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfDeferredRevenue">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_UndeliveredElementsExtendedWarrantyCurrent" xlink:label="biol_UndeliveredElementsExtendedWarrantyCurrent"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_UndeliveredElementsExtendedWarrantyNoncurrent" xlink:label="biol_UndeliveredElementsExtendedWarrantyNoncurrent"/>
<loc xlink:type="locator" xlink:href="biol-20130331.xsd#biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices" xlink:label="biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenue" xlink:to="biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenue" xlink:to="biol_UndeliveredElementsExtendedWarrantyCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="biol_UndeliveredElementsExtendedWarrantyNoncurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetRevenueByGeographicLocation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccountingChangesAndErrorCorrectionsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"> </calculationLink>
</linkbase>

Top
Filing Submission 0001193125-13-214464   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 16, 5:31:58.1pm ET